本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Atara Biotherapeutics

4.69
-0.3200-6.39%
成交量:8.00萬
成交額:37.93萬
市值:3,835.54萬
市盈率:1.82
高:5.04
開:5.03
低:4.44
收:5.01
52周最高:19.15
52周最低:3.92
股本:817.81萬
流通股本:560.06萬
量比:2.80
換手率:1.43%
股息:- -
股息率:- -
每股收益(TTM):2.57
每股收益(LYR):-11.4053
淨資產收益率:-2014.86%
總資產收益率:47.81%
市淨率:-1.00
市盈率(LYR):-0.41

資料載入中...

2021/09/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/10

重要事件披露

8-K - Current report
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/09

重要事件披露

8-K - Current report
2021/05/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/04

重要事件披露

8-K - Current report
2021/03/01

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/01

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2021/01/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/04

重要事件披露

8-K - Current report